These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1910603)

  • 21. Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: applications for detection of xenobiotics in biological samples.
    Poirier MC
    Mutat Res; 1993 Jul; 288(1):31-8. PubMed ID: 7686263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinogen-induced site-specific mutagenesis and genetic susceptibility in squamous cell carcinoma of the head and neck.
    Weber A; Tannapfel A; Wittekind C; Bootz F
    Onkologie; 2002 Feb; 25(1):8-13. PubMed ID: 11893877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of DNA adducts in smoking-related carcinogenesis].
    Schoket B
    Magy Onkol; 2004; 48(3):201-5. PubMed ID: 15520869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular and genetic epidemiology].
    Kang DH
    Exp Mol Med; 2001 Apr; 33(1 Suppl):73-82. PubMed ID: 11708327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins.
    Schut HA; Shiverick KT
    FASEB J; 1992 Aug; 6(11):2942-51. PubMed ID: 1644258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinogen-DNA adducts as a biomarker for cancer risk.
    Rundle A
    Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics: detecting sensitive populations.
    Shields PG
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):81-7. PubMed ID: 7737047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA adduct burden and tobacco carcinogenesis.
    Wiencke JK
    Oncogene; 2002 Oct; 21(48):7376-91. PubMed ID: 12379880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From single DNA adducts measurement to DNA adductomics in molecular epidemiology of cancer.
    Baer-Dubowska W; Szaefer H
    Postepy Biochem; 2024 May; 70(1):52-56. PubMed ID: 39016235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.
    Harris CC
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):435-9. PubMed ID: 8781359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
    Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
    Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology of lung cancer and the modulation of markers of chronic carcinogen exposure by chemopreventive agents.
    Perera FP; Tang D; Grinberg-Funes RA; Blackwood MA; Dickey C; Blaner W; Santella RM
    J Cell Biochem Suppl; 1993; 17F():119-28. PubMed ID: 8412183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular biology of tobacco smoke associated neoplasia].
    Zojer N; Fritsche R; Fiegl M; Schulte-Hermann R; Mannhalter C; Huber H
    Wien Klin Wochenschr; 1996; 108(18):574-81. PubMed ID: 9012141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
    Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA damage from polycyclic aromatic hydrocarbons measured by benzo[a]pyrene-DNA adducts in mothers and newborns from Northern Manhattan, the World Trade Center Area, Poland, and China.
    Perera F; Tang D; Whyatt R; Lederman SA; Jedrychowski W
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):709-14. PubMed ID: 15767354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens.
    Arif JM; Dresler C; Clapper ML; Gairola CG; Srinivasan C; Lubet RA; Gupta RC
    Chem Res Toxicol; 2006 Feb; 19(2):295-9. PubMed ID: 16485906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA adduct determination in humans.
    Poirier MC; Weston A
    Prog Clin Biol Res; 1991; 372():205-18. PubMed ID: 1956919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.